Differences in the management of toxic epidermal necrolysis related and unrelated to immune checkpoint inhibitors
European Journal of Dermatology · 2025
DOI: 10.1684/ejd.2025.4915 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Dermatology, 2025. Verfasst von Fumika Minakawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of dermatology, Kawasaki Medical School, Kurashiki, Japan. Hauptthemen laut MEDLINE: Stevens-Johnson Syndrome, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of dermatology, Kawasaki Medical School, Kurashiki, Japan.
- Department of dermatology, Hiroshima University, Hiroshima, Japan.
- Department of dermatology, Hiroshima Citizens Hospital, Hiroshima, Japan.
Zitieren
APA
Minakawa, F., Yanagida, N., Sugiyama, S., Toi, Y., Urakami, Y., Oka, D., Tanaka, R., Yamamoto, T., & Aoyama, Y. (2025). Differences in the management of toxic epidermal necrolysis related and unrelated to immune checkpoint inhibitors. European Journal of Dermatology. https://doi.org/10.1684/ejd.2025.4915
Vancouver
Minakawa F, Yanagida N, Sugiyama S, Toi Y, Urakami Y, Oka D, et al. Differences in the management of toxic epidermal necrolysis related and unrelated to immune checkpoint inhibitors. European Journal of Dermatology. 2025. doi:10.1684/ejd.2025.4915
BibTeX
@article{Minakawa2025,
author = {Minakawa, Fumika and Yanagida, Nozomi and Sugiyama, Seiko and Toi, Yoichiro and Urakami, Yosuke and Oka, Daigo and Tanaka, Ryo and Yamamoto, Takenobu and Aoyama, Yumi},
title = {Differences in the management of toxic epidermal necrolysis related and unrelated to immune checkpoint inhibitors},
journal = {European Journal of Dermatology},
year = {2025},
doi = {10.1684/ejd.2025.4915}
}
EUVIMED